10 research outputs found
Recommended from our members
Electrostatic Discharge (ESD) Protection for a Laser Diode Ignited Actuator
The use of laser diodes in devices to ignite pyrotechnics provides unique new capabilities including the elimination of electrostatic discharge (ESD) pulses entering the device. The Faraday cage formed by the construction of these devices removes the concern of inadvertent ignition of the energetic material. However, the laser diode itself can be damaged by ESD pulses, therefore, to enhance reliability, some protection of the laser diode is necessary. The development of the MC4612 Optical Actuator has included a circuit to protect the laser diode from ESD pulses including the ''Fisher'' severe human body ESD model. The MC4612 uses a laser diode and is designed to replace existing hot-wire actuators. Optical energy from a laser diode, instead of electrical energy, is used to ignite the pyrotechnic. The protection circuit is described along with a discussion of how the circuit design addresses and circumvents the historic 1Amp/1Watt requirement that has been applicable to hot-wire devices
Solar forcing of Florida Straits surface salinity during the early Holocene
[1] Previous studies showed that sea surface salinity (SSS) 18 O SW change due to continental ice volume variability, we find that early Holocene SSS enrichments are associated with increased evaporation/precipitation ratios in the Florida Straits during periods of reduced solar forcing, increased ice rafted debris in the North Atlantic and the development of more permanent El Niño-like conditions in the eastern equatorial Pacific. When considered with previous high-resolution reconstructions of Holocene tropical atmospheric circulation changes, our results provide evidence that variations in solar forcing over the early Holocene had a significant impact on the global tropical hydrologic cycle
Recommended from our members
An overview of semiconductor bridge, SCB, applications at Sandia National Laboratories
The semiconductor bridge, SCB, developed by Sandia National Laboratories is a maturing technology now being used in several applications by Sandia customers. Most applications arose because of a need at the system level to provide explosive assemblies that were light weight, small volume, low cost and required small quantities of electrical energy to function -- for the purposes of this paper we define an explosive assembly to mean the combination of the firing set and an explosive component. As a result, and because conventional firing systems could not meet the stringent size, weight and energy requirements of our customers, we designed and are investigating SCB applications that range from devices for Sandia applications to igniters for fireworks. We present in this paper an overview of SCB technology with specific examples of the system designed for our customers to meet modern requirements that sophisticated explosive systems must satisfy in today`s market environments
PREVENTion of CLots in Orthopaedic Trauma (PREVENT CLOT): a randomised pragmatic trial protocol comparing aspirin versus low-molecular-weight heparin for blood clot prevention in orthopaedic trauma patients
Introduction Patients who sustain orthopaedic trauma are at an increased risk of venous thromboembolism (VTE), including fatal pulmonary embolism (PE). Current guidelines recommend low-molecular-weight heparin (LMWH) for VTE prophylaxis in orthopaedic trauma patients. However, emerging literature in total joint arthroplasty patients suggests the potential clinical benefits of VTE prophylaxis with aspirin. The primary aim of this trial is to compare aspirin with LMWH as a thromboprophylaxis in fracture patients.Methods and analysis PREVENT CLOT is a multicentre, randomised, pragmatic trial that aims to enrol 12 200 adult patients admitted to 1 of 21 participating centres with an operative extremity fracture, or any pelvis or acetabular fracture. The primary outcome is all-cause mortality. We will evaluate non-inferiority by testing whether the intention-to-treat difference in the probability of dying within 90 days of randomisation between aspirin and LMWH is less than our non-inferiority margin of 0.75%. Secondary efficacy outcomes include cause-specific mortality, non-fatal PE and deep vein thrombosis. Safety outcomes include bleeding complications, wound complications and deep surgical site infections.Ethics and dissemination The PREVENT CLOT trial has been approved by the ethics board at the coordinating centre (Johns Hopkins Bloomberg School of Public Health) and all participating sites. Recruitment began in April 2017 and will continue through 2021. As both study medications are currently in clinical use for VTE prophylaxis for orthopaedic trauma patients, the findings of this trial can be easily adopted into clinical practice. The results of this large, patient-centred pragmatic trial will help guide treatment choices to prevent VTE in fracture patients.Trial registration number NCT02984384